Wird geladen...
ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer
BACKGROUND: Lung cancer is the leading cause of cancer-related deaths with 1.8 million new cases each year and poor 5-year prognosis. Promoter hypermethylation of tumour suppressors leads to their inactivation and thereby can promote cancer development and progression. RESULTS: In this study, we ana...
Gespeichert in:
| Veröffentlicht in: | Clin Epigenetics |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5457737/ https://ncbi.nlm.nih.gov/pubmed/28588743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-017-0360-4 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|